Moreover, a variety of plasma and CSF biomarkers are employed as pharmacodynamic biomarkers to determine the effects of semaglutide on peripheral inflammation, core biomarkers of AD, oxidative stress, vascular integrity, synaptic function, and BBB integrity
Chemical degradation of the peptide may theoretically produce breakdown products, though under labeled storage conditions, there is no evidence that semaglutide degradation generates toxic metabolites
Ozempic and Wegovy, both containing semaglutide, are injectable medications that effectively support weight loss
The encouraging part is that new trials are unlocking more uses every year, and some clinics including ours are already helping patients with chronic pain and autoimmune disease access these medications, including in microdoses, even when they dont fit the traditional weight-loss criteria
Click here for more news about obesity and weight-loss medications